MetLife Investment Management’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.76M | Sell |
41,461
-1,760
| -4% | -$324K | 0.04% | 462 |
|
|
2026
Q1 | $8.16M | Buy |
43,221
+290
| +0.7% | +$61.1K | 0.04% | 422 |
|
|
2025
Q4 | $8.53M | Sell |
42,931
-2,460
| -5% | -$497K | 0.04% | 409 |
|
|
2025
Q3 | $9.22M | Sell |
45,391
-4,605
| -9% | -$817K | 0.04% | 380 |
|
|
2025
Q2 | $8.8M | Sell |
49,996
-2,812
| -5% | -$423K | 0.05% | 356 |
|
|
2025
Q1 | $7.1M | Sell |
52,808
-799
| -1% | -$105K | 0.04% | 450 |
|
|
2024
Q4 | $6.77M | Buy |
53,607
+4,093
| +8% | +$609K | 0.04% | 404 |
|
|
2024
Q3 | $8.23M | Sell |
49,514
-1,911
| -4% | -$289K | 0.05% | 308 |
|
|
2024
Q2 | $6.84M | Sell |
51,425
-4,353
| -8% | -$524K | 0.04% | 347 |
|
|
2024
Q1 | $5.86M | Sell |
55,778
-1,471
| -3% | -$132K | 0.04% | 412 |
|
|
2023
Q4 | $4.33M | Sell |
57,249
-928
| -2% | -$58.8K | 0.03% | 553 |
|
|
2023
Q3 | $3.83M | Sell |
58,177
-2,892
| -5% | -$216K | 0.03% | 586 |
|
|
2023
Q2 | $4.97M | Sell |
61,069
-5,194
| -8% | -$370K | 0.04% | 446 |
|
|
2023
Q1 | $3.94M | Sell |
66,263
-1,773
| -3% | -$98.6K | 0.03% | 602 |
|
|
2022
Q4 | $3.32M | Sell |
68,036
-1,219
| -2% | -$56.3K | 0.03% | 678 |
|
|
2022
Q3 | $3.57M | Sell |
69,255
-768
| -1% | -$45.6K | 0.03% | 586 |
|
|
2022
Q2 | $3.68M | Sell |
70,023
-53,720
| -43% | -$3.74M | 0.03% | 612 |
|
|
2022
Q1 | $10.6M | Buy |
123,743
+35,165
| +40% | +$2.89M | 0.07% | 223 |
|
|
2021
Q4 | $7.24M | Buy |
88,578
+485
| +0.6% | +$35.4K | 0.06% | 271 |
|
|
2021
Q3 | $5.85M | Sell |
88,093
-3,051
| -3% | -$216K | 0.05% | 306 |
|
|
2021
Q2 | $6.11M | Sell |
91,144
-3,235
| -3% | -$201K | 0.05% | 307 |
|
|
2021
Q1 | $4.91M | Sell |
94,379
-6,456
| -6% | -$326K | 0.04% | 396 |
|
|
2020
Q4 | $4.03M | Sell |
100,835
-6,064
| -6% | -$196K | 0.04% | 454 |
|
|
2020
Q3 | $2.62M | Sell |
106,899
-1,846
| -2% | -$47.2K | 0.03% | 607 |
|
|
2020
Q2 | $1.97M | Buy |
108,745
+5,154
| +5% | +$102K | 0.02% | 717 |
|
|
2020
Q1 | $1.49M | Hold |
103,591
| – | – | 0.02% | 726 |
|
|
2019
Q4 | $3.94M | Sell |
103,591
-3,095
| -3% | -$92.7K | 0.04% | 472 |
|
|
2019
Q3 | $2.36M | Buy |
106,686
+10,676
| +11% | +$227K | 0.03% | 716 |
|
|
2019
Q2 | $1.98M | Sell |
96,010
-171,197
| -64% | -$3.95M | 0.02% | 821 |
|
|
2019
Q1 | $7.71M | Buy |
267,207
+178,206
| +200% | +$4.4M | 0.02% | 691 |
|
|
2018
Q4 | $1.53M | Sell |
89,001
-154
| -0.2% | -$3.73K | 0.02% | 875 |
|
|
2018
Q3 | $2.54M | Sell |
89,155
-646
| -0.7% | -$21.3K | 0.03% | 764 |
|
|
2018
Q2 | $3.02M | Buy |
89,801
+834
| +0.9% | +$25.9K | 0.04% | 605 |
|
|
2018
Q1 | $2.16M | Sell |
88,967
-614
| -0.7% | -$12.2K | 0.03% | 753 |
|
|
2017
Q4 | $1.36M | Buy |
+89,581
| New | +$1.26M | 0.02% | 912 |
|
Other funds holding THC
GCM
MetLife Investment Management's THC Position: Q2 2026 in Review
MetLife Investment Management reduced its Tenet Healthcare (THC) stake by 4.1% in Q2 2026, selling an estimated $324K and leaving 41,461 shares worth $7.76M. The position accounts for 0.04% of the portfolio, ranked #462.
MetLife Investment Management first reported a position in THC in Q4 2017 and has held it in 35 quarters since. The position peaked at $10.6M in Q1 2022. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- MetLife Investment Management held 41,461 shares of Tenet Healthcare worth $7.76M as of Q2 2026.
- MetLife Investment Management sold 1,760 Tenet Healthcare shares in Q2 2026, an estimated $324K.
- Tenet Healthcare made up 0.04% of MetLife Investment Management's portfolio in Q2 2026, its #462 holding.
- MetLife Investment Management first reported a position in Tenet Healthcare in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Tenet Healthcare position peaked at $10.6M in Q1 2022.
- 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.